Stay updated on S64315 Combo with Azacitidine in AML Clinical Trial
Sign up to get notified when there's something new on the S64315 Combo with Azacitidine in AML Clinical Trial page.

Latest updates to the S64315 Combo with Azacitidine in AML Clinical Trial page
- Check6 days agoChange DetectedAdded a new revision entry for v3.5.2 and removed the v3.5.0 entry from the revision history.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check35 days agoChange DetectedRevision history now shows the addition of v3.5.0 and the deletion of v3.4.3.SummaryDifference0.1%

- Check42 days agoChange DetectedAdded a new site revision entry (v3.4.3) and removed the previous revision (v3.4.2). This is an internal versioning update and does not modify study data or visible content.SummaryDifference0.1%

- Check70 days agoChange DetectedA new revision entry, Revision: v3.4.2, was added to the study record history. Older notices about government funding and operating status were removed.SummaryDifference0.8%

- Check77 days agoChange DetectedAdded a government funding lapse notice and a new revision tag (v3.4.1). The prior revision (v3.4.0) was removed.SummaryDifference0.8%

- Check84 days agoChange DetectedVersion history now includes a glossary toggle and color-coded change highlights. The revision label changes from v3.3.4 to v3.4.0 and the No FEAR Act data marker is removed.SummaryDifference1%

Stay in the know with updates to S64315 Combo with Azacitidine in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the S64315 Combo with Azacitidine in AML Clinical Trial page.